MediXall Group, Inc. (MDXL)
OTCMKTS · Delayed Price · Currency is USD
0.0039
+0.0004 (11.43%)
At close: Mar 31, 2025
MediXall Group Market Cap
MediXall Group has a market cap or net worth of $851.90 thousand as of August 22, 2025. Its market cap has decreased by -98.83% in one year.
Market Cap
851.90K
Enterprise Value
4.68M
Revenue
331.01K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since December 20, 2016, MediXall Group's market cap has decreased from 3.64M to 851.90K, a decrease of -76.60%. That is a compound annual growth rate of -16.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2025 | 851.90K | -98.90% |
| Dec 23, 2022 | 77.59M | -31.76% |
| Dec 28, 2021 | 113.70M | 28.06% |
| Dec 28, 2020 | 88.79M | -41.36% |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 610.45M |
| Glass House Brands | 554.44M |
| Nika Pharmaceuticals | 453.04M |
| CytoDyn | 363.56M |
| Northwest Biotherapeutics | 355.76M |
| American Oncology Network | 355.44M |